Two Chinese firms bid for NZ honey maker Manuka Health: source
[HONG KONG] Two Chinese firms have bid for New Zealand honey maker Manuka Health, pricing the firm around US$300 million, a source with direct knowledge of the sale said on Monday.
The source declined to name the firms, however the Australian Financial Review newspaper reported Beijing-based private equity investor CDH Investments was a bidder.
CDH did not immediately respond to a request for comment, nor did a spokeswoman for Auckland-based Manuka Health. A spokesman for its owner, Australian private equity firm Pacific Equity Partners, had no immediate comment.
REUTERS
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Sheng Siong Q1 net profit up 9.3% on higher revenue
Nestle sales growth sputters on US slump, vitamin snags
Hermes Q1 sales jump 17% on strong China demand
Cordlife’s independent auditor to retire after issuing disclaimer of opinion on FY2023 financials
Cutting the cord?: Events leading up to Cordlife’s MOH suspension and arrests of its directors, ex-group CEO
Cordlife customers push for legal action